MedPath

Diacerein

Generic Name
Diacerein
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C19H12O8
CAS Number
13739-02-1
Unique Ingredient Identifier
4HU6J11EL5
Background

Diacerein is a prodrug which is metabolized to rhein. It is currently approved in France for the treatment of osteoarthritis although the use of diacerein is restricted due to the side effects including severe diarrhea . Diacerein is under investigation for the treatment of Insulin Resistance, Diabetes Mellitus (Type 2), and Diabetes-Related Complications.

Indication

For the treatment of osteoarthritis affecting the hip or knee .

Associated Conditions
Osteoarthritis in the Hip Joint, Osteoarthritis of the Knee
Associated Therapies
-

Safety and Efficacy of the Combination of Diacerein 100 mg Daily and MTX Versus MTX Alone in the Treatment of Early Rheumatoid Arthritis (RA)

Phase 2
Completed
Conditions
Rheumatoid Arthritis
Interventions
Drug: Diacerein
Drug: Placebo
First Posted Date
2010-12-21
Last Posted Date
2015-11-05
Lead Sponsor
TRB Chemedica
Target Recruit Count
40
Registration Number
NCT01264211
Locations
🇹🇭

Juree Rawdmanee, Sukhumvit, Bangkok, Thailand

🇹🇭

Faculty of medicine, Chiangmai University, Chiangmai, Thailand

Diacerein as Adjuvant to Diclofenac Sodium in Indian Patients of Osteoarthritis (OA) Knee

Phase 4
Completed
Conditions
Osteoarthritis
Osteoarthritis, Knee
Interventions
First Posted Date
2010-05-10
Last Posted Date
2010-05-31
Lead Sponsor
Government Medical College, Amritsar
Target Recruit Count
84
Registration Number
NCT01120015
Locations
🇮🇳

Kuljinder Singh, Amritsar, Punjab, India

Effect of Diacerein on Hand Osteoarthritis

Phase 4
Completed
Conditions
Osteoarthritis
Interventions
Drug: diacerein
Drug: placebo
First Posted Date
2008-05-28
Last Posted Date
2010-12-03
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
86
Registration Number
NCT00685542
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Chondromodulating Effect of Diacerein in Osteoarthritis of the Hip

Phase 3
Completed
Conditions
Hip Osteoarthritis
First Posted Date
2007-03-23
Last Posted Date
2008-07-25
Lead Sponsor
Laboratoires NEGMA
Target Recruit Count
500
Registration Number
NCT00451360
Locations
🇫🇷

Hôpital Nord, Amiens, France

🇫🇷

Hôpital Ambroise Paré, Boulogne, France

🇫🇷

CH Lyon Sud, Pierre Bénite, France

and more 21 locations

Symptomatic Efficacy of Diacerein in Knee Osteoarthritis

Phase 4
Completed
Conditions
Knee Osteoarthritis
First Posted Date
2007-03-08
Last Posted Date
2010-03-04
Lead Sponsor
Laboratoires NEGMA
Target Recruit Count
500
Registration Number
NCT00445276
Locations
🇫🇷

Chu Trousseau, Tours, France

© Copyright 2025. All Rights Reserved by MedPath